Literature DB >> 11870910

Reproducibility of quantitative dynamic MRI of normal human tissues.

Anwar R Padhani1, Carmel Hayes, Sabine Landau, Martin O Leach.   

Abstract

The aim of the study was to establish the normal range and to evaluate the reproducibility of dynamic contrast enhanced MRI (DCE-MRI) parameter estimates in normal human pelvic tissues. Nineteen patients with prostate cancer, undergoing androgen deprivation treatment, had paired DCE-MRI examinations of the pelvis using spoiled gradient-echo sequences. Quantitative enhancement parameters were calculated for each examination: transfer constant (K(trans)), leakage space (v(e)) and maximum contrast medium accumulation (MCMA) of pelvic muscles, bone marrow and fat. Descriptive and reproducibility statistics were calculated: within-patient standard deviation (wSD), repeatability and within-patient coefficient of variation (wCV). The femoral head and ischiorectal fat showed large numbers of non-enhancing pixels (81 and 88%, respectively). The ischial bone marrow had the highest values of kinetic parameter estimates (K(trans) 0.554 min(-1), v(e) 18.5% and MCMA 0.164 mmol/kg). Muscle parameters values were lower (K(trans) 0.126-0.137 min(-1), v(e) 10.6-11.5% and MCMA 0.077-0.086 mmol/kg). The mean difference between paired examinations was not significantly different from zero for any parameter. v(e) and MCMA had the lowest wCV (between 19 and 29%). For individuals, a log(10) K(trans) change of approximately 0.90 in muscles and 0.52 in the ischium would be statistically significant. The corresponding absolute changes for v(e) are 6.7% in muscle and 13.6% in the ischium. For a group of 19 patients, small changes are statistically significant (muscle log(10) K(trans) 0.208 and v(e) 1.5% and ischium log(10) K(trans) 0.123 and v(e) 3.1%). Fat and the femoral head are unreliable tissues from which to obtain kinetic parameter estimates due to poor enhancement. v(e) and MCMA have smaller coefficient of variation than K(trans) in muscles and ischium. Reproducibility studies of normal and pathological tissues should be incorporated into clinical research protocols that measure treatment effects by DCE-MRI techniques. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870910     DOI: 10.1002/nbm.732

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  61 in total

Review 1.  Multicentre imaging measurements for oncology and in the brain.

Authors:  P S Tofts; D J Collins
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  MRI of blood-brain barrier permeability in cerebral ischemia.

Authors:  Quan Jiang; James R Ewing; Michael Chopp
Journal:  Transl Stroke Res       Date:  2012-03       Impact factor: 6.829

3.  Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.

Authors:  Thomas E Yankeelov; Martin Lepage; Anuradha Chakravarthy; Elizabeth E Broome; Kenneth J Niermann; Mark C Kelley; Ingrid Meszoely; Ingrid A Mayer; Cheryl R Herman; Kevin McManus; Ronald R Price; John C Gore
Journal:  Magn Reson Imaging       Date:  2006-11-21       Impact factor: 2.546

4.  Dynamic contrast-enhanced MR imaging to assess physiologic variations of myometrial perfusion.

Authors:  Isabelle Thomassin-Naggara; Daniel Balvay; Charles A Cuenod; Emile Daraï; Claude Marsault; Marc Bazot
Journal:  Eur Radiol       Date:  2009-10-10       Impact factor: 5.315

5.  Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer.

Authors:  Binsheng Zhao; Leonard P James; Chaya S Moskowitz; Pingzhen Guo; Michelle S Ginsberg; Robert A Lefkowitz; Yilin Qin; Gregory J Riely; Mark G Kris; Lawrence H Schwartz
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

6.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.

Authors:  Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
Journal:  Eur Radiol       Date:  2006-10-27       Impact factor: 5.315

Review 7.  Methods and challenges in quantitative imaging biomarker development.

Authors:  Richard G Abramson; Kirsteen R Burton; John-Paul J Yu; Ernest M Scalzetti; Thomas E Yankeelov; Andrew B Rosenkrantz; Mishal Mendiratta-Lala; Brian J Bartholmai; Dhakshinamoorthy Ganeshan; Leon Lenchik; Rathan M Subramaniam
Journal:  Acad Radiol       Date:  2015-01       Impact factor: 3.173

8.  A linear algorithm of the reference region model for DCE-MRI is robust and relaxes requirements for temporal resolution.

Authors:  Julio Cárdenas-Rodríguez; Christine M Howison; Mark D Pagel
Journal:  Magn Reson Imaging       Date:  2012-12-08       Impact factor: 2.546

9.  Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer.

Authors:  Stephanie L Barnes; Jennifer G Whisenant; Mary E Loveless; Gregory D Ayers; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2012-07-27       Impact factor: 4.668

10.  Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis.

Authors:  Cheng Yang; Gregory S Karczmar; Milica Medved; Aytekin Oto; Marta Zamora; Walter M Stadler
Journal:  Magn Reson Med       Date:  2009-04       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.